NorthRock Partners LLC Has $601,000 Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

NorthRock Partners LLC raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 205.6% in the fourth quarter, Holdings Channel reports. The institutional investor owned 2,002 shares of the company’s stock after buying an additional 1,347 shares during the quarter. NorthRock Partners LLC’s holdings in HCA Healthcare were worth $601,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Sanders Capital LLC increased its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company’s stock worth $3,498,417,000 after purchasing an additional 116,826 shares during the period. First Eagle Investment Management LLC raised its holdings in HCA Healthcare by 0.5% in the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock valued at $1,351,830,000 after acquiring an additional 23,177 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of HCA Healthcare by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company’s stock worth $1,159,882,000 after purchasing an additional 50,321 shares in the last quarter. Capital World Investors raised its stake in shares of HCA Healthcare by 0.7% in the fourth quarter. Capital World Investors now owns 2,928,452 shares of the company’s stock valued at $878,975,000 after purchasing an additional 19,121 shares in the last quarter. Finally, Norges Bank bought a new stake in HCA Healthcare in the 4th quarter valued at $840,286,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $385.66 on Friday. The firm has a market capitalization of $92.78 billion, a P/E ratio of 17.55, a PEG ratio of 1.10 and a beta of 1.46. The business has a 50-day moving average of $339.43 and a 200-day moving average of $328.55. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. During the same period last year, the business posted $5.36 earnings per share. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.75%. HCA Healthcare’s dividend payout ratio is presently 12.81%.

Insiders Place Their Bets

In other news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.30% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on HCA. Baird R W lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Guggenheim started coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating for the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. Barclays reduced their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Finally, Robert W. Baird restated a “neutral” rating and issued a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $381.13.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.